Old Web
English
Sign In
Acemap
>
authorDetail
>
Raghad Muhsin Abdul-Karim
Raghad Muhsin Abdul-Karim
in patient
Medicine
Cancer research
Atezolizumab
Oncology
4
Papers
1
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Phase I study of BJ-001, a tumor-targeting interleukin-15 fusion protein, in patients with solid tumor.
2021
Journal of Clinical Oncology
Ki Y Chung
Haeseong Park
Raghad Muhsin Abdul-Karim
Deborah Blythe Doroshow
Jorge Chaves
Teresa A. Coleman
Keiko Nakai
Pankaj C. Patel
John Qiang Wang
Haizhou Zhang
Leijun Hu
Show All
Source
Cite
Save
Citations (0)
Initial results from a phase 1b study of ORIC-101, a glucocorticoid receptor antagonist, in combination with nab-paclitaxel in patients with advanced solid tumors.
2021
Journal of Clinical Oncology
Raghad Muhsin Abdul-Karim
Anthony W. Tolcher
S. Kummar
Manish R. Patel
Alexander I. Spira
Shekeab Jauhari
Maureen Duff
Rongda Xu
Ann M. Johnson
Anneleen Daemen
Pratik S. Multani
Edna Chow Maneval
Pamela N. Munster
Show All
Source
Cite
Save
Citations (0)
Results of a phase 1 dose-escalation study of AMV564, a novel T-cell engager, alone and in combination with pembrolizumab in patients with relapsed/refractory solid tumors.
2021
Journal of Clinical Oncology
Niharika B. Mettu
Alexander Starodub
Sarina Anne Piha-Paul
Raghad Muhsin Abdul-Karim
Gabriel Tinoco
Michael Rahman Shafique
Victoria C. Smith
Christina Baccei
Patrick Chun
Show All
Source
Cite
Save
Citations (0)
Derazantinib (DZB) in combination with atezolizumab (AZB) in patients with solid tumors: Results from the dose-finding phase Ib substudy of FIDES-02.
2021
Journal of Clinical Oncology
Raghad Muhsin Abdul-Karim
Arvind Chaudhry
Anna Patrikidou
Alejandro Gonzalez
Fabricio Racca
Yohann Loriot
Damien Pouessel
Jean-Laurent Deville
Hyo Jin Lee
Frédérique Cantero
Michalina Marszewska
Mikael Saulay
Stephan Braun
Rodryg Ramlau
Show All
Source
Cite
Save
Citations (1)
1